Michalle Soudack

Michalle Soudack

Auto-generated profile, based on publicly available information

Michalle Soudack

Division of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Israel

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ASAmos J. Simon
Amos J. Simon
ALAtar Lev
Atar Lev
YZYong Zhang
Yong Zhang
BWBatia Weiss
Batia Weiss
ARAnna Rylova
Anna Rylova
RSRaz Somech
Raz Somech
The analysis of individuals with telomere defects may shed light on the delicate interplay of factors controlling genome stability, premature aging, and cancer. We herein describe two Coats plus patients with telomere and genomic defects; both harbor distinct, novel mutations in STN1, a member of the human CTC1–STN1–TEN1 (CST) complex, thus linking this gene for the first time to a human telomeropathy. We characterized the patients’ phenotype, recapitulated it in a zebrafish model and rescued cellular and clinical aspects by the ectopic expression of wild-type STN1 or by thalidomide treatment. Interestingly, a significant lengthy control of the gastrointestinal bleeding in one of our patients was achieved by thalidomide treatment, exemplifying a successful bed-to-bench-and-back approach.

4 August 2017 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
MCMougnyan Cox
Mougnyan Cox
MSMichalle Soudack
Michalle Soudack
DPDaniel J. Podberesky
Daniel J. Podberesky
MEMonica Epelman
Monica Epelman

12 January 2012 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
MSMichalle Soudack
Michalle Soudack
ABAviva Ben-Shlush
Aviva Ben-Shlush
JJJeffrey Jacobson
Jeffrey Jacobson
LRLisa Raviv-Zilka
Lisa Raviv-Zilka
IEIris Eshed
Iris Eshed
OHOrit Hamiel
Orit Hamiel

4 June 2018 in BMC Pediatrics
Verified
Journal Article
Open access
PDF file
AKAlex Krauthammer
Alex Krauthammer
ALAvishay Lahad
Avishay Lahad
LGLior Goldberg
Lior Goldberg
ISIfat Sarouk
Ifat Sarouk
BWBatia Weiss
Batia Weiss
IPItai M. Pessach
Itai M. Pessach
Ataxia telangiectasia (AT) is a rare, multi-systemic, genetic disorder. Mutations in the ATM gene cause dysfunction in cell-cycle, apoptosis and V (D) J recombination leading to neurodegeneration, cellular, humoral immunodeficiencies and predisposition to malignancies. Previous studies have suggested that a sub-group of AT patients with elevated IgM levels have a distinct and more severe phenotype. In the current study we aimed to better characterize this group of patients. We performed a retrospective review of 46 patient records, followed from January 1986 to January 2015 at the Israeli National AT Center. Demographic, clinical, radiological, laboratory data was reviewed and compared between AT patients with elevated IgM levels (EIgM) and patients with normal IgM levels (NIgM). 15/46(32.6%) patients had significantly elevated IgM levels. This group had a unique phenotype characterized mainly by increased risk of infection and early mortality. Colonization of lower respiratory tract with Mycobacterium gordonae and Pseudomonas aeruginosa as well as viral skin infections were more frequent in EIgM patients. Patients with NIgM had a significantly longer survival as compared to patients with EIgM but had an increased incidence of fatty liver or cirrhosis. T-cell recombination excision circles and kappa-deleting element recombination circle levels were significantly lower in the EIgM group, suggesting an abnormal class switching in this group. EIgM in AT patients are indicative of a more severe phenotype that probably results from a specific immune dysfunction. EIgM in AT should be considered a unique AT phenotype that may require different management.

10 October 2015 in Pediatric Radiology
Verified
Journal Article
Closed access
PDF file
SSShai Shrot
Shai Shrot
GBGalia Barkai
Galia Barkai
ABAviva Ben-Shlush
Aviva Ben-Shlush
MSMichalle Soudack
Michalle Soudack

30 April 2020 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
AKA. Kerpel
A. Kerpel
MYM. Yalon
M. Yalon
MSM. Soudack
M. Soudack
JCJ. Chiang
J. Chiang
AGA. Gajjar
A. Gajjar
CHC. Hoffmann
C. Hoffmann
BACKGROUND AND PURPOSE: Constitutional mismatch repair deficiency is a hereditary childhood cancer predisposition syndrome characterized by brain tumors and colorectal and hematologic malignancies. Our objective was to describe the neuroimaging findings in patients with constitutional mismatch repair deficiency. MATERIALS AND METHODS: This retrospective study included 14 children with genetically confirmed constitutional mismatch repair deficiency who were referred to 2 tertiary pediatric oncology centers. RESULTS: Fourteen patients from 11 different families had diagnosed constitutional mismatch repair deficiency. The mean age at presentation was 9.3 years (range, 5–14 years). The most common clinical presentation was brain malignancy, diagnosed in 13 of the 14 patients. The most common brain tumors were glioblastoma (n = 7 patients), anaplastic astrocytoma (n = 3 patients), and diffuse astrocytoma (n = 3 patients). Nonspecific subcortical white matter T2 hyperintensities were noted in 10 patients (71%). Subcortical hyperintensities transformed into overt brain tumors on follow-up imaging in 3 patients. Additional non-neoplastic brain MR imaging findings included developmental venous anomalies in 12 patients (85%) and nontherapy-induced cavernous hemangiomas in 3 patients (21%). CONCLUSIONS: On brain MR imaging, these patients have both highly characteristic intra-axial tumors (typically multifocal high-grade gliomas) and nonspecific findings, some of which might represent early stages of neoplastic transformation. The incidence of developmental venous anomalies is high in these patients for unclear reasons. Awareness of these imaging findings, especially in combination, is important to raise the suspicion of constitutional mismatch repair deficiency in routine diagnostic imaging evaluation or surveillance imaging studies of asymptomatic carriers because early identification of the phenotypic “gestalt” might improve outcomes.